Invention Grant
- Patent Title: Inhibitors of indoleamine 2,3-dioxygenase
-
Application No.: US15578861Application Date: 2016-06-30
-
Publication No.: US10239894B2Publication Date: 2019-03-26
- Inventor: Wieslaw Mieczyslaw Kazmierski , Martha Alicia De La Rosa , Vicente Samano
- Applicant: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
- Applicant Address: GB Brentford, Middlesex
- Assignee: GlaxoSmithKline Intellectual Property Development Limited
- Current Assignee: GlaxoSmithKline Intellectual Property Development Limited
- Current Assignee Address: GB Brentford, Middlesex
- Agent Robert H. Brink; Kathryn A. Lutomski; Edward R. Gimmi
- International Application: PCT/IB2016/053947 WO 20160630
- International Announcement: WO2017/002078 WO 20170105
- Main IPC: C07F5/02
- IPC: C07F5/02 ; A61P37/06
Abstract:
Provided are compounds of formula (I) and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and methods for their use in the prevention and/or treatment of HIV; including the prevention of the progression of AIDS and general immunosuppression.
Public/Granted literature
- US20180298035A1 INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE Public/Granted day:2018-10-18
Information query
